Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-89
Closed -$31.3K 14
2026
Q1
$31.3K Buy
+89
New +$31.7K ﹤0.01% 152
2022
Q4
Sell
-1,947
Closed -$439K 204
2022
Q3
$439K Buy
+1,947
New +$472K 0.04% 252
2021
Q4
Sell
-590
Closed -$125K 39
2021
Q3
$125K Buy
590
+502
+570% +$116K 0.01% 302
2021
Q2
$21K Buy
88
+76
+633% +$18.7K ﹤0.01% 259
2021
Q1
$3K Sell
12
-188
-94% -$44.9K ﹤0.01% 242
2020
Q4
$46K Buy
+200
New +$46.1K ﹤0.01% 129

Other funds holding AMGN

QVR's AMGN Position: Q2 2026 in Review

QVR sold out of Amgen (AMGN) in Q2 2026, closing a stake of 89 shares — an estimated $31.3K sold.

QVR first reported a position in AMGN in Q4 2020 and held it in 6 quarters. The position peaked at $439K in Q3 2022. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • QVR reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • QVR sold 89 Amgen shares in Q2 2026, an estimated $31.3K.
  • QVR first reported a position in Amgen in Q4 2020 and held it in 6 quarters.
  • QVR's Amgen position peaked at $439K in Q3 2022.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on QVR's 13F filing for Q2 2026.